| Anti-inflammatory effects of rebamipide according to Helicobacter pylori status in patients with chronic erosive gastritis: a randomized sucralfate-controlled multicenter trial in China-STARS study. | |
MedLine Citation:
|
PMID: 18288617 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The aim of the study was to investigate the effects of rebamipide on symptom, histology, endogenous prostaglandin, and mucosal oxygen free radicals in chronic erosive gastritis (CEG) patients by using sucralfate as a control. The trial also examined whether Helicobacter pylori infection would affect rebamipide-induced protection. A total of 453 endoscopy-confirmed CEG patients from 11 hospitals in China were enrolled in the study. They randomly received either rebamipide (100 mg t.i.d) or sucralfate (1.0 t.i.d) for 8 weeks with a ratio of 3:1. Per-protocol analysis (n = 415) showed the accumulated symptom score in the rebamipide group dropped from 5.54 +/- 0.97 to 0.80 +/- 0.47 after 8 weeks (P < 0.001 versus control). The endoscopic inflammation score in rebamipide group also decreased from 2.65 +/- 0.09 to 0.60 +/- 0.10, which showed better effects than sucralfate. It was shown a significant improvement (P < 0.01) in prostaglandin E2 (PGE(2)) contents in rebamipide-treated subjects mucosa (225.4 +/- 18.3 pg/g versus 266.7 +/- 14.7 pg/g) compared with that in sucralfate group after 8 weeks of treatment. Malondialdehyde (MDA) contents were significantly depressed both in the trial and control group. When Helicobacter pylori infection was considered, no statistically difference was found in the effect of rebamipide on either symptom or inflammation scores. In conclusion, Rebamipide demonstrated a stronger suppressive effect on the mucosal inflammation in chronic erosive gastritis than sucralfate. The gastroprotection induced by rebamipide is not influenced by H. pylori infection, which indicates its usage in the treatment of H. pylori-associated CEG. |
Authors:
|
Yiqi Du; Zhaoshen Li; Xianbao Zhan; Jie Chen; Jun Gao; Yanfang Gong; Jianlin Ren; Liping He; Zhijian Zhang; Xiaozhong Guo; Jianshen Wu; Zibin Tian; Ruihua Shi; Bo Jiang; Dianchun Fang; Youming Li |
Related Documents
:
|
9248117 - Lansoprazole versus omeprazole in the treatment of reflux esophagitis. 10987767 - Systematic review and economic evaluation of helicobacter pylori eradication treatment ... 10978947 - Bismuth-based triple therapy with bismuth subcitrate, metronidazole and tetracycline in... 25420377 - The relationship between meaning of illness, anxiety depression, and quality of life fo... 19941077 - Efficiency of static and computer adaptive short forms compared to full-length measures... 569567 - The epidemiology of depressive disorder. |
Publication Detail:
|
Type: Journal Article; Multicenter Study; Randomized Controlled Trial Date: 2008-02-21 |
Journal Detail:
|
Title: Digestive diseases and sciences Volume: 53 ISSN: 0163-2116 ISO Abbreviation: Dig. Dis. Sci. Publication Date: 2008 Nov |
Date Detail:
|
Created Date: 2008-10-13 Completed Date: 2008-12-09 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7902782 Medline TA: Dig Dis Sci Country: United States |
Other Details:
|
Languages: eng Pagination: 2886-95 Citation Subset: AIM; IM |
Affiliation:
|
Department of Gastroenterology, Changhai Hospital, Second Military Medical University, Shanghai, 200433, China. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Alanine / analogs & derivatives*, therapeutic use Anti-Inflammatory Agents / therapeutic use* Anti-Ulcer Agents / therapeutic use* China Dinoprostone / metabolism Female Gastric Mucosa / metabolism, microbiology Gastritis / drug therapy*, ethnology, microbiology* Helicobacter Infections / complications* Helicobacter pylori / pathogenicity Humans Male Malondialdehyde / metabolism Middle Aged Quinolones / therapeutic use* Sucralfate / therapeutic use* |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Inflammatory Agents; 0/Anti-Ulcer Agents; 0/Quinolones; 111911-87-6/rebamipide; 363-24-6/Dinoprostone; 54182-58-0/Sucralfate; 542-78-9/Malondialdehyde; 56-41-7/Alanine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Microbiology and management of abdominal infections.
Next Document: An automated method for cell detection in zebrafish.